Seres Therapeutics (United States)
- Research works
- 40 ▲ 1122% vs 2013–17
- Citations
- 593 14.8 per fractional work
- Top-10% rate
- 10.9% record average 16.5%
- Open access
- 60% world 28%
Not ranked overall: Seres Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.7×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 4.7×
- Biochemistry, Genetics and Molecular Biology 3.8×
- Earth and Planetary Sciences 3.7×
- Physics and Astronomy 3.6×
- Medicine 2.5×
- Immunology and Microbiology 2.5×
- Agricultural and Biological Sciences 1.0×
- Decision Sciences 0.9×
- Mathematics 0.8×
- Arts and Humanities 0.6×
- Nursing 0.4×
- Health Professions 0.2×
- Social Sciences 0.2×
- Engineering 0.1×
- Environmental Science 0.1×
Who are the top researchers at Seres Therapeutics (United States)?
Ranked on the composite score, Christopher McChalicher lead among researchers whose main affiliation is Seres Therapeutics (United States).
- 1 Christopher McChalicher United States · #1,630,831 worldwide 6 citations · 16 works
Which keywords describe research at Seres Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Healthcare-Associated Infections, Microbial Communities, Inflammatory Diseases, Gut Microbiota, Metagenomic Analysis, Short-Chain Fatty Acids, Epidemiology and Clinical Practice Guidelines.
- Microscopic Colitis
- Inflammatory Bowel Disease
- Pancreatic Cancer
- Cancer
- Antibiotic Resistance
- Neoadjuvant Therapy
- Mars
- Immunotherapy
- Probiotics
- PD-1 and PD-L1
- Tumor Microenvironment
- Fecal Microbiota Transplantation
- Clinical Practice Guidelines
- Metagenomic Analysis
- Gut Microbiota
- Healthcare-Associated Infections
- Epidemiology
- Microbial Communities
- Inflammatory Diseases
- Short-Chain Fatty Acids
- Antibiotic-Associated Diarrhea
- Chemotherapy
- Immune Checkpoint Blockade
- Inflammation
- Microbiota
- ICU
- Martian Surface
- Ventilator-associated Pneumonia
- Antimicrobial Agents
- Febrile Neutropenia
- Surgical Complications
- Collagenous Colitis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 32 words, with their numbers
- Epidemiology8▲ 5.3×13 topics
- Healthcare-Associated Infections8▲ 167×2 topics
- Microbial Communities8▲ 56×3 topics
- Gut Microbiota8▲ 56×2 topics
- Inflammatory Diseases8▲ 160×2 topics
- Metagenomic Analysis7▲ 327×1 topic
- Short-Chain Fatty Acids7▲ 327×1 topic
- Clinical Practice Guidelines7▲ 31×2 topics
- Antibiotic-Associated Diarrhea7▲ 613×1 topic
- Fecal Microbiota Transplantation7▲ 613×1 topic
- Chemotherapy4▲ 13×8 topics
- Tumor Microenvironment4▲ 25×2 topics
- Immune Checkpoint Blockade2▲ 101×1 topic
- PD-1 and PD-L12▲ 101×1 topic
- Inflammation2▲ 2.2×8 topics
- Probiotics2▲ 19×4 topics
- Microbiota2▲ 20×2 topics
- Immunotherapy2▲ 6.1×4 topics
- ICU2▲ 131×1 topic
- Mars2▲ 77×1 topic
- Martian Surface2▲ 77×1 topic
- Neoadjuvant Therapy2▲ 17×2 topics
- Ventilator-associated Pneumonia2▲ 131×1 topic
- Antibiotic Resistance1▲ 8.4×5 topics
- Antimicrobial Agents1▲ 188×1 topic
- Cancer1▲ 2.6×2 topics
- Febrile Neutropenia1▲ 188×1 topic
- Pancreatic Cancer1▲ 28×1 topic
- Surgical Complications1▲ 46×1 topic
- Inflammatory Bowel Disease1▲ 27×2 topics
- Collagenous Colitis1▲ 100×1 topic
- Microscopic Colitis1▲ 100×1 topic
Which research topics does Seres Therapeutics (United States) publish most on?
By volume in 2022–2025: Clostridium difficile and Clostridium perfringens research, Gut microbiota and health, Planetary Science and Exploration and Nosocomial Infections in ICU.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Clostridium difficile and Clostridium perfringens research Infectious Diseases 3 works
- 2 Gut microbiota and health Molecular Biology 3 works
- 3 Planetary Science and Exploration Astronomy and Astrophysics 2 works
- 4 Nosocomial Infections in ICU Critical Care and Intensive Care Medicine 1 works
- 5 Probiotics and Fermented Foods Food Science 1 works
- 6 Neutropenia and Cancer Infections Oncology 1 works
- 7 Microbial Metabolism and Applications Biotechnology 0 works
- 8 Microscopic Colitis Epidemiology 0 works
- 9 Remote Sensing and Land Use Atmospheric Science 0 works
- 10 Liver Disease Diagnosis and Treatment Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Seres Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 1122% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.